NCT05431387Phase 2Completed

A Study of Cytisinicline for Vaping Cessation in Adult Smokers

Study sponsor: Achieve Life Sciences

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-02-28Actual
Enrollment · participants160Actual
Source updated2026-01-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Proportion of Participants With Vaping Abstinence During Weeks 9 to 12. After: Measure: Percentage of Participants With Vaping Abstinence From Week 9 to 12.

Check registry source